These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15875714)

  • 21. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I.
    Boothman DA; Trask DK; Pardee AB
    Cancer Res; 1989 Feb; 49(3):605-12. PubMed ID: 2535961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
    Baloch Z; Cohen S; Coffman FD
    J Immunol; 1990 Nov; 145(9):2908-13. PubMed ID: 2170526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells.
    López-Lázaro M; Willmore E; Elliott SL; Austin CA
    Int J Cancer; 2008 Nov; 123(9):2217-21. PubMed ID: 18712718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.
    Ciesielski MJ; Fenstermaker RA
    J Neurooncol; 1999 Feb; 41(3):223-34. PubMed ID: 10359142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dependence of etoposide-induced cytotoxicity and topoisomerase II-mediated DNA strand breakage on the intracellular ionic environment.
    Lawrence TS; Canman CE; Maybaum J; Davis MA
    Cancer Res; 1989 Sep; 49(17):4775-9. PubMed ID: 2547516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors.
    Chen AY; Yu C; Gatto B; Liu LF
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8131-5. PubMed ID: 7690143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteins of the origin recognition complex (ORC) and DNA topoisomerases on mammalian chromatin.
    Hu HG; Baack M; Knippers R
    BMC Mol Biol; 2009 Apr; 10():36. PubMed ID: 19397829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 dependence of topoisomerase I recruitment in vivo.
    Mao Y; Okada S; Chang LS; Muller MT
    Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, DNA binding, topoisomerase inhibition and cytotoxic properties of 2-chloroethylnitrosourea derivatives of hoechst 33258.
    Bielawski K; Bielawska A; Anchim T; Wołczyński S
    Biol Pharm Bull; 2005 Jun; 28(6):1004-9. PubMed ID: 15930735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells.
    Dunkern TR; Kaina B
    Mol Biol Cell; 2002 Jan; 13(1):348-61. PubMed ID: 11809844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
    Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.
    Chashoo G; Singh SK; Sharma PR; Mondhe DM; Hamid A; Saxena A; Andotra SS; Shah BA; Qazi NA; Taneja SC; Saxena AK
    Chem Biol Interact; 2011 Jan; 189(1-2):60-71. PubMed ID: 21056033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive and supraadditive interaction between ionizing radiation and pazelliptine, a DNA topoisomerase inhibitor, in Chinese hamster V-79 fibroblasts.
    Balosso J; Giocanti N; Favaudon V
    Cancer Res; 1991 Jun; 51(12):3204-11. PubMed ID: 1645614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide.
    Giocanti N; Hennequin C; Balosso J; Mahler M; Favaudon V
    Cancer Res; 1993 May; 53(9):2105-11. PubMed ID: 8386982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of topoisomerase I in the induction of DNA-protein crosslinks and DNA single-strand breaks in cells of ultraviolet-irradiated human and frog cell lines.
    Rosenstein BS; Subramanian D; Muller MT
    Radiat Res; 1997 Dec; 148(6):575-9. PubMed ID: 9399703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GL331, a topoisomerase II inhibitor, induces radiosensitization of human glioma cells.
    Chen Y; Lin TY; Chen JC; Yang HZ; Tseng SH
    Anticancer Res; 2006; 26(3A):2149-56. PubMed ID: 16827158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
    Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
    Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.